156 related articles for article (PubMed ID: 26085442)
1. Challenges for the European governance of synthetic biology for human health.
Douglas CM; Stemerding D
Life Sci Soc Policy; 2014 Dec; 10():6. PubMed ID: 26085442
[TBL] [Abstract][Full Text] [Related]
2. Co-evolution of physical and social sciences in synthetic biology.
Trump BD; Cegan J; Wells E; Poinsatte-Jones K; Rycroft T; Warner C; Martin D; Perkins E; Wood MD; Linkov I
Crit Rev Biotechnol; 2019 May; 39(3):351-365. PubMed ID: 30727764
[TBL] [Abstract][Full Text] [Related]
3. Safety risks and ethical governance of biomedical applications of synthetic biology.
Ou Y; Guo S
Front Bioeng Biotechnol; 2023; 11():1292029. PubMed ID: 37941726
[No Abstract] [Full Text] [Related]
4. Synthetic biology regulation and governance: Lessons from TAPIC for the United States, European Union, and Singapore.
Trump BD
Health Policy; 2017 Nov; 121(11):1139-1146. PubMed ID: 28807332
[TBL] [Abstract][Full Text] [Related]
5. Governing biotechnology to provide safety and security and address ethical, legal, and social implications.
Trump B; Cummings C; Klasa K; Galaitsi S; Linkov I
Front Genet; 2022; 13():1052371. PubMed ID: 36712887
[TBL] [Abstract][Full Text] [Related]
6. Synthetic biology and the prospects for responsible innovation.
Macnaghten P; Owen R; Jackson R
Essays Biochem; 2016 Nov; 60(4):347-355. PubMed ID: 27903822
[TBL] [Abstract][Full Text] [Related]
7. The art of trans-boundary governance: the case of synthetic biology.
Zhang JY
Syst Synth Biol; 2013 Sep; 7(3):107-14. PubMed ID: 24432148
[TBL] [Abstract][Full Text] [Related]
8. Steering vaccinomics innovations with anticipatory governance and participatory foresight.
Ozdemir V; Faraj SA; Knoppers BM
OMICS; 2011 Sep; 15(9):637-46. PubMed ID: 21848419
[TBL] [Abstract][Full Text] [Related]
9. Anticipating governance challenges in synthetic biology: Insights from biosynthetic menthol.
Ribeiro B; Shapira P
Technol Forecast Soc Change; 2019 Feb; 139():311-320. PubMed ID: 30774160
[TBL] [Abstract][Full Text] [Related]
10. Beyond Cost-Benefit Analysis in the Governance of Synthetic Biology.
Wallach W; Saner M; Marchant G
Hastings Cent Rep; 2018 Jan; 48 Suppl 1():S70-S77. PubMed ID: 29453841
[TBL] [Abstract][Full Text] [Related]
11. Synthetic biology's self-fulfilling prophecy--dangers of confinement from within and outside.
Frank D; Heil R; Coenen C; König H
Biotechnol J; 2015 Feb; 10(2):231-5. PubMed ID: 25515923
[TBL] [Abstract][Full Text] [Related]
12. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
13. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health.
Schneider I
Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920
[TBL] [Abstract][Full Text] [Related]
14. Implantable nano-neurotechnological devices: consideration of ethical, legal, and social issues and implications.
Giordano J; Akhouri R; McBride D
J Long Term Eff Med Implants; 2009; 19(1):83-93. PubMed ID: 20402632
[TBL] [Abstract][Full Text] [Related]
15. Engineering imaginaries: Anticipatory foresight for solar radiation management governance.
Low S
Sci Total Environ; 2017 Feb; 580():90-104. PubMed ID: 28011016
[TBL] [Abstract][Full Text] [Related]
16. Clinical genetic research 3: Genetics ELSI (Ethical, Legal, and Social Issues) research.
Pullman D; Etchegary H
Methods Mol Biol; 2015; 1281():369-82. PubMed ID: 25694322
[TBL] [Abstract][Full Text] [Related]
17. Comparative, collaborative, and integrative risk governance for emerging technologies.
Linkov I; Trump BD; Anklam E; Berube D; Boisseasu P; Cummings C; Ferson S; Florin MV; Goldstein B; Hristozov D; Jensen KA; Katalagarianakis G; Kuzma J; Lambert JH; Malloy T; Malsch I; Marcomini A; Merad M; Palma-Oliveira J; Perkins E; Renn O; Seager T; Stone V; Vallero D; Vermeire T
Environ Syst Decis; 2018 May; 38(2):170-176. PubMed ID: 37829286
[TBL] [Abstract][Full Text] [Related]
18. Challenges and opportunities for ELSI early career researchers.
Bell J; Ancillotti M; Coathup V; Coy S; Rigter T; Tatum T; Grewal J; Akcesme FB; Brkić J; Causevic-Ramosevac A; Milovanovic G; Nobile M; Pavlidis C; Finlay T; Kaye J;
BMC Med Ethics; 2016 Jul; 17(1):37. PubMed ID: 27390930
[TBL] [Abstract][Full Text] [Related]
19. A life scientist, an engineer and a social scientist walk into a lab: challenges of dual-use engagement and education in synthetic biology.
Edwards B; Kelle A
Med Confl Surviv; 2012; 28(1):5-18. PubMed ID: 22606757
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
